Advertisements
-
Recent Posts
- Digital Therapeutics: A threat or opportunity to pharmaceuticals March 18, 2019
- Immunoediting can be a constant defense in the cancer landscape March 16, 2019
- Immunotherapy may help in glioblastoma survival March 16, 2019
- 2018 CEO’s Compensation in Health Companies – Highest $99 Million to mid range $20 Million March 14, 2019
- Lesson 5 Cell Signaling And Motility: Cytoskeleton & Actin: Curations and Articles of reference as supplemental information: #TUBiol3373 March 13, 2019
- 2019 Koch Institute Symposium – Machine Learning and Cancer, June 14, 2019, 8:00 AM-5:00 PMET MIT Kresge Auditorium, 48 Massachusetts Ave, Cambridge, MA March 12, 2019
- Mitralign and Corvia, Tewksbury, Mass – Investment and Acquisition by Edwards Lifesciences March 11, 2019
- VIDEOS: Artificial Intelligence Applications for Cardiology March 11, 2019
- At California Central District Court Juno Therapeutics, Inc. et al v. Kite Pharma, Inc. – Multi-party Patent Infringement March 11, 2019
- Tips on 280 Character Tweets on Twitter.com March 10, 2019
Archives
Categories
Meta
-
2012pharmaceutical
-
Aashir Awan, Phd
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
amnondanzig1724
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Dror Nir
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jdpmd
-
kellyperlman
-
Ed Kislauskis
-
larryhbern
-
lmulligan13gmailcom
-
marzankhan
-
megbaker58
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
sjwilliamspa
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
zraviv06
-
zs22
-
Advertisements
